S173: T‐CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM THE MODE OF ACTION OF RG6234, A NOVEL GPRC5D T‐CELL ENGAGING BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.
Autor: | Dekhtiarenko, I., Lelios, I., Attig, J., Sleiman, N., Lazzaro, D., Clausen, I., Gräfe, N., Helms, H.‐J., Schindler, E., Belli, S., Fauti, T., Eckmann, J., Umana, P., Jacob, W., Schneider, M., Hasselbalch Riley, C., Hutchings, M., Yoon, S.‐S., Koh, Y, Manier, S. |
---|---|
Zdroj: | HemaSphere; 2022 Supplement 3, Vol. 6, p74-75, 2p |
Databáze: | Complementary Index |
Externí odkaz: |